Tag Archives: vaccines

Everything You Need to Know About Priority Review Vouchers: Part 2 of 2

The Rare Pediatric Disease PRV, the Difference in the PRVs, and the Future of the Program The Rare Pediatric Disease Priority Review Voucher (If you haven’t read Part 1 yet, start there first!) A new Priority Review Voucher (PRV) has … Continue reading

Posted in Clinical Trials, FDA, Regulatory Strategy | Tagged , , , , , , , , , | 1 Comment

New FDA Guidances Released in May 2012

Here’s a list of the  guidances released by FDA in April 2012, compiled by Cato Research Scientist Elinore Mercer, Ph.D. Pediatric Information for X-ray Imaging Device Premarket Notifications (Draft) S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals Pathologic Complete Response in … Continue reading

Posted in FDA, Industry News | Tagged , , , , , , , , , , , , | Comments Off on New FDA Guidances Released in May 2012

New FDA Guidances – December 2011/January 2012

Here’s a list of the notable guidances released by FDA in December 2011 and January 2012, compiled by Cato Research Regulatory Scientist Cathy Anderson. December 2011 FDA Portable Document Format (PDF) Specifications (Updated) (More info on this guidance can be … Continue reading

Posted in FDA | Tagged , , , , , , , , , , , , , , | Comments Off on New FDA Guidances – December 2011/January 2012

2010 New Drug Approvals

The U.S. FDA’s Center for Drug Evaluation and Research (CDER) approved 21 new products in 2010 – slightly less than the previous year’s 24 – plus 5 biologics approved by CBER. In light of the FDA’s continued focus on drug safety, I am not surprised that the number isn’t higher. A full list of approvals can be found here.

While the list isn’t long, a few new products stand out to me. Continue reading

Posted in FDA, Industry News, Regulatory Strategy | Tagged , , , , , , , , , , , | Comments Off on 2010 New Drug Approvals

Google Insights – A Tool for Smarter Clinical Site Selection

Every year, epidemics of the seasonal flu cause major health concerns and numerous deaths around the world.  Vaccines are made in massive quantities and extra precautions are taken, such as hand washing of children in schools, in an effort to … Continue reading

Posted in Clinical Trials | Tagged , , , , , | Comments Off on Google Insights – A Tool for Smarter Clinical Site Selection